FULVESTRANT (ful VES trant) blocks the effects of estrogen. It is used to treat breast cancer in women past the age of menopause.
Fulvestrant (trade name Faslodex, by AstraZeneca) is a drug treatment of
hormone receptor-positive metastatic breast cancer in postmenopausal women
Fulvestrant is a synthetic estrogen receptor antagonist. Unlike tamoxifen (which
has partial agonist effects) and the aromatase inhibitors (which reduce the ...
Learn about the prescription medication Faslodex (Fulvestrant), drug uses,
dosage, side effects, drug interactions, warnings, reviews and patient labeling.
This page contains brief information about fulvestrant and a collection of links to
more information about the use of this drug, research results, and ongoing ...
(fool-VES-trant). Trade names: Faslodex<sup>®</sup>. Chemocare.com uses generic names
in all descriptions of drugs. Faslodex is the trade name for fulvestrant. In some ...
Official patient Web site for FASLODEX® (fulvestrant) Injection 500 mg, a
treatment option for postmenopausal women with hormone receptor-positive
Apr 16, 2014 ... Consumer information about the medication FULVESTRANT - INJECTION (
Faslodex), includes side effects, drug interactions, recommended ...
Fulvestrant is known as a hormonal breast cancer treatment. It is used to treat
advanced breast cancer and metastatic breast cancer.
Faslodex (fulvestrant) is an anti-estrogen medication. It works by blocking the
actions of estrogen in the body. Certain types of breast cancer use estrogen to ...